Zetia and Vytorin Personal Injury and Out of Pocket Expense Investigation
KGS is investigating lawsuits related to the cholesterol-lowering drugs Zetia (ezetimibe) and Vytorin (a combination of ezetimibe and simvastatin). Zetia was introduced in 2002, and by 2003, it was on the list of top-selling drugs with more than 4.2 million prescriptions written that year. The combination drug Vytorin was introduced one year later, in 2004, but the FDA reviewer of Vytorin recommended against approval of Vytorin. (For excerpts of the recommendation, see www.worstpills.org/public/newsletter.cfm?n_id=353)

Hometeam Pest Defense Tubes-in-the-wall or floor Customers May Have a Claim
The HomeTeam Pest Defense Company, a subsidiary of Centex Corporation, provides built-in home pest treatments through a tubes-in-the-wall or tubes-in-the-floor pest defense system. However, some individuals who have the tubes-in-the-wall or tubes-in-the-floor pest defense system have found it to be an ineffective system. Independent tests of the tubes-in-the-wall or tubes-in-the-floor pest defense system have also questioned the effectiveness of the system. Our office is currently investigating the tubes-in-the-wall or tubes-in-the-floor pest defense system. If you have this system in your home and believe that it is not working, please call to speak with a lawyer about our investigation at 1-866-467-1400, ext. 100, or you can make a claim on this page.

INVESTOR ALERT: China Sunergy Co. Ltd. Investors Have Only Until 11/9/2007 To File Lead Plaintiff Motion in Class Action Lawsuit
Kahn Gauthier Swick, LLC (“KGS”) has filed the first class action lawsuit against China Sunergy Co. Ltd. (“China Sunergy” or the “Company”) (NasdaqGM: CSUN) in the United States District Court for the Southern District of New York, on behalf of shareholders who purchased the common stock of China Sunergy in connection with the Company’s IPO on or about May 17, 2007, or who purchased shares thereafter in the open market. No class has yet been certified in this action.